Collagen Market to cross $10 Billion by 2032, Says Global Market Insights inc.
December 08, 2022 19:00 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Dec. 08, 2022 (GLOBE NEWSWIRE) -- As per the report published by Global Market Insights Inc., Global Collagen Market the was estimated at USD 4 billion in 2022 and is...
Vestaron Closes Another $10M in Series C Funding to Fuel Product Development and Market Expansion
August 25, 2022 11:30 ET
|
Vestaron
RTP, North Carolina, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Vestaron, a leader in peptide-based biological crop protection, announced the addition of $10M to its Series C fundraising, adding Grosvenor...
Global Cosmetic Bioactive Ingredients Market to Grow with a CAGR ~5% During 2022-2031; Market to Grow on the Back of Increasing Usage of Cosmetic Products, Rising Awareness about Healthy Skin and Hair, and Growing Cosmetic Industry
July 25, 2022 10:02 ET
|
Research Nester
New York, July 25, 2022 (GLOBE NEWSWIRE) -- As per a cosmetic survey, around 80% of American women are considered to use cosmetics daily, which translates to 161 million people spending USD 15,000...
Vestaron Closes Series C Funding at $82M
May 16, 2022 09:00 ET
|
Vestaron
RTP, North Carolina, May 16, 2022 (GLOBE NEWSWIRE) -- Vestaron, a leader in peptide-based biological crop protection, is pleased to announce the official closing of the Series C fundraising efforts...
CordenPharma enters into a technology alliance agreement with Nanos of South Korea
March 29, 2021 08:49 ET
|
CordenPharma
SEOUL, South Korea, March 29, 2021 (GLOBE NEWSWIRE) -- CordenPharma of Germany entered into a technology alliance agreement with Nanos (151910 KOSDAQ) of South Korea relating to the production of...
Collagen Market revenue to hit $6 billion by 2026, Says Global Market Insights, Inc.
May 21, 2020 05:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, May 21, 2020 (GLOBE NEWSWIRE) -- Global Collagen Market is anticipated to exceed USD 6 billion by 2026, according to a new research report by Global Market Insights, Inc....
CohBar Confirms Anti-fibrotic Effect of a Novel Peptide in a Therapeutic Model of Idiopathic Pulmonary Fibrosis
December 16, 2019 09:00 ET
|
CohBar, Inc.
MENLO PARK, Calif., Dec. 16, 2019 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR), a clinical stage biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related...
Arch Therapeutics Announces Participation at the 2013 Boulder Peptide Symposium in Colorado September 25-27
September 20, 2013 09:00 ET
|
Arch Therapeutics, Inc.
CAMBRIDGE, MA--(Marketwired - Sep 20, 2013) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), today announced it will be featured as a presenting company at the Boulder Peptide...
Vyteris and Zealand Pharma Announce Agreement on Active Transdermal Patch for Peptide Drugs
April 14, 2009 08:00 ET
|
Vyteris, Inc.
FAIR LAWN, NJ--(Marketwire - April 14, 2009) - Vyteris, Inc. (OTCBB: VYTR), developer of the
first FDA-approved active transdermal drug delivery system and a leader in
active transdermal drug...